HealthEquity (NASDAQ: HQY) reported Q4 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $46.8 million versus the consensus estimate of $45.59 million.

• Revenue of $46.8 million, an increase of 30% compared to Q4 FY16.
• Net income of $4.1 million, an increase of 30% compared to Q4 FY16.
• Net income per diluted share of $0.07 compared to $0.05 in Q4 FY16.
• Adjusted EBITDA of $11.8 million, an increase of 33% compared to Q4 FY16.

For earnings history and earnings-related data on HealthEquity (HQY) click here.